Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 25586 | 30.6907 |
09:33 ET | 16274 | 30.62 |
09:35 ET | 11356 | 30.77 |
09:37 ET | 33964 | 31.2 |
09:39 ET | 80817 | 31.3453 |
09:42 ET | 178775 | 31.54 |
09:44 ET | 167490 | 31.23 |
09:46 ET | 25768 | 31.41 |
09:48 ET | 22259 | 31.4 |
09:50 ET | 40411 | 31.75 |
09:51 ET | 110119 | 31.57 |
09:53 ET | 21512 | 31.64 |
09:55 ET | 30628 | 31.63 |
09:57 ET | 5256 | 31.5639 |
10:00 ET | 16306 | 31.58 |
10:02 ET | 16109 | 31.24 |
10:04 ET | 10360 | 31.48 |
10:06 ET | 12808 | 31.34 |
10:08 ET | 47967 | 31.471 |
10:09 ET | 39647 | 31.84 |
10:11 ET | 81235 | 31.88 |
10:13 ET | 26047 | 31.8188 |
10:15 ET | 14864 | 31.77 |
10:18 ET | 8327 | 31.655 |
10:20 ET | 9052 | 31.495 |
10:22 ET | 33263 | 31.6299 |
10:24 ET | 18668 | 31.69 |
10:26 ET | 12096 | 31.66 |
10:27 ET | 8652 | 31.71 |
10:29 ET | 5804 | 31.63 |
10:31 ET | 9769 | 31.54 |
10:33 ET | 17498 | 31.715 |
10:36 ET | 16222 | 31.85 |
10:38 ET | 100182 | 31.93 |
10:40 ET | 24000 | 31.73 |
10:42 ET | 15596 | 31.64 |
10:44 ET | 26337 | 31.77 |
10:45 ET | 15027 | 31.9 |
10:47 ET | 91256 | 32.12 |
10:49 ET | 18460 | 32.0236 |
10:51 ET | 13656 | 32.08 |
10:54 ET | 19171 | 32.3 |
10:56 ET | 18439 | 32.3539 |
10:58 ET | 78203 | 32.31 |
11:00 ET | 24607 | 32.2501 |
11:02 ET | 17518 | 32 |
11:03 ET | 18617 | 32.09 |
11:05 ET | 29594 | 32.07 |
11:07 ET | 12127 | 31.91 |
11:09 ET | 14153 | 32.03 |
11:12 ET | 8993 | 31.96 |
11:14 ET | 10789 | 32.025 |
11:16 ET | 7540 | 31.955 |
11:18 ET | 5430 | 31.9374 |
11:20 ET | 8498 | 32 |
11:21 ET | 20027 | 32.085 |
11:23 ET | 10696 | 31.98 |
11:25 ET | 6801 | 31.97 |
11:27 ET | 10288 | 32.13 |
11:30 ET | 14168 | 32.25 |
11:32 ET | 7625 | 32.35 |
11:34 ET | 47153 | 32.28 |
11:36 ET | 8309 | 32.28 |
11:38 ET | 15914 | 32.35 |
11:39 ET | 8765 | 32.43 |
11:41 ET | 10011 | 32.45 |
11:43 ET | 25166 | 32.22 |
11:45 ET | 20007 | 32.0468 |
11:48 ET | 19898 | 31.925 |
11:50 ET | 13661 | 31.955039 |
11:52 ET | 2680 | 32.06 |
11:54 ET | 7997 | 32.21 |
11:56 ET | 17070 | 32.25 |
11:57 ET | 74467 | 32.123 |
11:59 ET | 17036 | 31.95 |
12:01 ET | 8832 | 31.85 |
12:03 ET | 21449 | 31.775 |
12:06 ET | 8397 | 32 |
12:08 ET | 2329 | 32.02 |
12:10 ET | 7743 | 31.9 |
12:12 ET | 2699 | 31.98 |
12:14 ET | 14951 | 31.8119 |
12:15 ET | 2929 | 31.903461 |
12:17 ET | 4126 | 31.89 |
12:19 ET | 2806 | 31.88 |
12:21 ET | 10005 | 31.795 |
12:24 ET | 27849 | 31.62 |
12:26 ET | 7449 | 31.7 |
12:28 ET | 3815 | 31.71 |
12:30 ET | 5497 | 31.74 |
12:32 ET | 5853 | 31.77 |
12:33 ET | 8785 | 31.75 |
12:35 ET | 5587 | 31.7 |
12:37 ET | 1955 | 31.6 |
12:39 ET | 8162 | 31.655 |
12:42 ET | 28477 | 31.57 |
12:44 ET | 16420 | 31.675 |
12:46 ET | 21015 | 31.76 |
12:48 ET | 11129 | 31.715 |
12:50 ET | 6825 | 31.725 |
12:51 ET | 3077 | 31.74 |
12:53 ET | 10405 | 31.66 |
12:55 ET | 8282 | 31.66 |
12:57 ET | 13611 | 31.66 |
01:00 ET | 2250 | 31.74 |
01:02 ET | 4614 | 31.52 |
01:04 ET | 12018 | 31.67 |
01:06 ET | 8957 | 31.7 |
01:08 ET | 6987 | 31.82 |
01:09 ET | 13588 | 31.86 |
01:11 ET | 6969 | 31.9 |
01:13 ET | 7722 | 31.705 |
01:15 ET | 5849 | 31.78 |
01:18 ET | 4679 | 31.73 |
01:20 ET | 5054 | 31.7376 |
01:22 ET | 2814 | 31.78 |
01:24 ET | 6820 | 31.76 |
01:26 ET | 4470 | 31.77 |
01:27 ET | 3139 | 31.8761 |
01:29 ET | 8410 | 31.825 |
01:31 ET | 5808 | 31.86 |
01:33 ET | 8702 | 31.87 |
01:36 ET | 4663 | 31.835 |
01:38 ET | 8208 | 31.88 |
01:40 ET | 15078 | 31.94 |
01:42 ET | 25547 | 32.04 |
01:44 ET | 5904 | 32 |
01:45 ET | 4745 | 32.06 |
01:47 ET | 5234 | 32.07 |
01:49 ET | 4523 | 32.11 |
01:51 ET | 8936 | 32.1735 |
01:54 ET | 8518 | 32.15 |
01:56 ET | 5900 | 32.07 |
01:58 ET | 6571 | 32.1009 |
02:00 ET | 4690 | 32.06 |
02:02 ET | 19770 | 32.0401 |
02:03 ET | 2989 | 32.07 |
02:05 ET | 10367 | 32 |
02:07 ET | 1699 | 32.07 |
02:09 ET | 16483 | 32.19 |
02:12 ET | 9840 | 32.015 |
02:14 ET | 11927 | 32.05 |
02:16 ET | 600 | 32.015 |
02:18 ET | 8321 | 31.83 |
02:20 ET | 9810 | 31.9 |
02:21 ET | 1939 | 31.93 |
02:23 ET | 2735 | 31.9207 |
02:25 ET | 1750 | 31.92 |
02:27 ET | 11591 | 31.99 |
02:30 ET | 4224 | 32.04 |
02:32 ET | 2669 | 32.049719 |
02:34 ET | 19215 | 31.92 |
02:36 ET | 3290 | 31.915 |
02:38 ET | 16795 | 32.05 |
02:39 ET | 7683 | 32.02 |
02:41 ET | 4412 | 31.975 |
02:43 ET | 54664 | 31.99 |
02:45 ET | 11605 | 31.96 |
02:48 ET | 2874 | 32.01 |
02:50 ET | 7526 | 32 |
02:52 ET | 1209 | 31.97 |
02:54 ET | 10803 | 31.9 |
02:56 ET | 12164 | 31.69 |
02:57 ET | 14481 | 31.675 |
02:59 ET | 5687 | 31.68 |
03:01 ET | 17991 | 31.78 |
03:03 ET | 9190 | 31.7094 |
03:06 ET | 4787 | 31.64 |
03:08 ET | 15012 | 31.62 |
03:10 ET | 2062 | 31.59 |
03:12 ET | 2672 | 31.625 |
03:14 ET | 5599 | 31.61 |
03:15 ET | 3801 | 31.54 |
03:17 ET | 4566 | 31.52 |
03:19 ET | 13026 | 31.52 |
03:21 ET | 29275 | 31.5 |
03:24 ET | 12053 | 31.5 |
03:26 ET | 7065 | 31.44 |
03:28 ET | 6249 | 31.2468 |
03:30 ET | 40539 | 31.255 |
03:32 ET | 37993 | 31.2309 |
03:33 ET | 19442 | 31.311 |
03:35 ET | 12838 | 31.331 |
03:37 ET | 43375 | 31.415 |
03:39 ET | 41361 | 31.36 |
03:42 ET | 80187 | 31.415 |
03:44 ET | 18513 | 31.415 |
03:46 ET | 53201 | 31.4 |
03:48 ET | 24762 | 31.1605 |
03:50 ET | 44856 | 31.02 |
03:51 ET | 102981 | 31.05 |
03:53 ET | 15820 | 31.12 |
03:55 ET | 36167 | 31.28 |
03:57 ET | 79463 | 31.0844 |
04:00 ET | 639773 | 30.91 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 4.8B | -289.7x | --- |
Axsome Therapeutics Inc | 4.4B | -15.3x | --- |
ADMA Biologics Inc | 5.3B | 154.9x | --- |
Denali Therapeutics Inc | 4.5B | -10.8x | --- |
CRISPR Therapeutics AG | 4.7B | -18.1x | --- |
Ultragenyx Pharmaceutical Inc | 4.7B | -7.4x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.8B |
---|---|
Revenue (TTM) | $264.8M |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.20 |
EPS | $-0.11 |
Book Value | $1.06 |
P/E Ratio | -289.7x |
Price/Sales (TTM) | 18.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -0.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.